| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 7th, 2004 | 31 | No |
19545-26-7; C15181; Wortmannin
CPD-11924; wortmanin; wortmannin
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.84 | 8.68 | -13.81 | 0 | 8 | 0 | 109 | 428.437 | 4 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 1.21e-01 g/l | DrugBank-experimental |
| MP | 240 °C | Fluorochem |
| Purity | >98% | Fluorochem |
| UniProt Database Links | ACTN4_HUMAN; ENPP3_HUMAN; MYLK_HUMAN; P3C2A_HUMAN; P3C2A_MOUSE; P3C2A_PONAB; P4KA1_ARATH; P4KB1_ARATH; PI4KA_BOVIN; PI4KA_HUMAN; PI4KA_RAT; PI4KB_BOVIN; PI4KB_CALJA; PI4KB_CALMO; PI4KB_HUMAN; PI4KB_MOUSE; PI4KB_OTOGA; PI4KB_PAPAN; PI4KB_RAT; PI4KB_RHIFE | ChEBI |
| Target | PI3K | Selleck Chemicals |
| Reactome Database Links | REACT_147854 | ChEBI |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| MTOR-2-E | Serine/threonine-protein Kinase MTOR (cluster #2 Of 3), Eukaryotic | Eukaryotes | 40 | 0.33 | Binding ≤ 10μM |
| MYLK-1-E | Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.24 | Binding ≤ 10μM |
| P85A-2-E | PI3-kinase P85-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1 | 0.41 | Binding ≤ 10μM |
| P85B-2-E | PI3-kinase P85-beta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5 | 0.37 | Binding ≤ 10μM |
| PK3CA-2-E | PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5 | 0.37 | Binding ≤ 10μM |
| PK3CB-2-E | PI3-kinase P110-beta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 5 | 0.37 | Binding ≤ 10μM |
| PK3CD-2-E | PI3-kinase P110-delta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 9 | 0.36 | Binding ≤ 10μM |
| PK3CG-3-E | PI3-kinase P110-gamma Subunit (cluster #3 Of 3), Eukaryotic | Eukaryotes | 89 | 0.32 | Binding ≤ 10μM |
| PLK1-1-E | Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6 | 0.37 | Binding ≤ 10μM |
| PLK3-1-E | Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 49 | 0.33 | Binding ≤ 10μM |
| PRKDC-1-E | DNA-dependent Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.31 | Binding ≤ 10μM |
| Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 10000 | 0.23 | Functional ≤ 10μM |
| Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 98 | 0.32 | Functional ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| PRKDC_HUMAN | P78527 | DNA-dependent Protein Kinase, Human | 120 | 0.31 | Binding ≤ 1μM |
| MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 40 | 0.33 | Binding ≤ 1μM |
| MYLK_CHICK | P11799 | Myosin Light Chain Kinase, Smooth Muscle, Chick | 260 | 0.30 | Binding ≤ 1μM |
| MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 170 | 0.31 | Binding ≤ 1μM |
| PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 1 | 0.41 | Binding ≤ 1μM |
| PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 10 | 0.36 | Binding ≤ 1μM |
| PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 4 | 0.38 | Binding ≤ 1μM |
| PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 19 | 0.35 | Binding ≤ 1μM |
| P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 1.2 | 0.40 | Binding ≤ 1μM |
| P85B_HUMAN | O00459 | PI3-kinase P85-beta Subunit, Human | 4.2 | 0.38 | Binding ≤ 1μM |
| PLK1_HUMAN | P53350 | Serine/threonine-protein Kinase PLK1, Human | 5.8 | 0.37 | Binding ≤ 1μM |
| PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 220 | 0.30 | Binding ≤ 1μM |
| PRKDC_HUMAN | P78527 | DNA-dependent Protein Kinase, Human | 120 | 0.31 | Binding ≤ 10μM |
| MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 40 | 0.33 | Binding ≤ 10μM |
| MYLK_CHICK | P11799 | Myosin Light Chain Kinase, Smooth Muscle, Chick | 260 | 0.30 | Binding ≤ 10μM |
| MYLK_HUMAN | Q15746 | Myosin Light Chain Kinase, Smooth Muscle, Human | 170 | 0.31 | Binding ≤ 10μM |
| PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 1 | 0.41 | Binding ≤ 10μM |
| PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 10 | 0.36 | Binding ≤ 10μM |
| PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 4 | 0.38 | Binding ≤ 10μM |
| PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 19 | 0.35 | Binding ≤ 10μM |
| P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 1.2 | 0.40 | Binding ≤ 10μM |
| P85B_HUMAN | O00459 | PI3-kinase P85-beta Subunit, Human | 4.2 | 0.38 | Binding ≤ 10μM |
| PLK1_HUMAN | P53350 | Serine/threonine-protein Kinase PLK1, Human | 1300 | 0.27 | Binding ≤ 10μM |
| PLK3_HUMAN | Q9H4B4 | Serine/threonine-protein Kinase PLK3, Human | 220 | 0.30 | Binding ≤ 10μM |
| Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.23 | Functional ≤ 10μM |
| Z50597 | Z50597 | Rattus Norvegicus | 98 | 0.32 | Functional ≤ 10μM |
| Description | Species |
|---|---|
| Constitutive PI3K/AKT Signaling in Cancer |
| Description | Species |
|---|---|
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
| CD28 dependent PI3K/Akt signaling | |
| Condensation of Prophase Chromosomes | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| Costimulation by the CD28 family | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cytosolic sensors of pathogen-associated DNA | |
| DAP12 signaling | |
| Downstream signal transduction | |
| Downstream TCR signaling | |
| G alpha (12/13) signalling events | |
| G alpha (q) signalling events | |
| G beta:gamma signalling through PI3Kgamma | |
| GAB1 signalosome | |
| Golgi Cisternae Pericentriolar Stack Reorganization | |
| GP1b-IX-V activation signalling | |
| GPVI-mediated activation cascade | |
| HSF1-dependent transactivation | |
| Interleukin receptor SHC signaling | |
| Interleukin-3, 5 and GM-CSF signaling | |
| Interleukin-7 signaling | |
| IRF3-mediated induction of type I IFN | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| Mitotic Metaphase/Anaphase Transition | |
| Mitotic Prometaphase | |
| Mitotic Telophase/Cytokinesis | |
| mTOR signalling | |
| Nephrin interactions | |
| Nonhomologous End-joining (NHEJ) | |
| Phosphorylation of Emi1 | |
| Phosphorylation of the APC/C | |
| PI-3K cascade | |
| PI3K Cascade | |
| PI3K events in ERBB2 signaling | |
| PI3K events in ERBB4 signaling | |
| PI3K/AKT activation | |
| PIP3 activates AKT signaling | |
| Polo-like kinase mediated events | |
| Processing of DNA ends prior to end rejoining | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Regulation of signaling by CBL | |
| Release of eIF4E | |
| Resolution of Sister Chromatid Cohesion | |
| Rho GTPase cycle | |
| Role of LAT2/NTAL/LAB on calcium mobilization | |
| Role of phospholipids in phagocytosis | |
| S6K1-mediated signalling | |
| Separation of Sister Chromatids | |
| Signaling by constitutively active EGFR | |
| Signaling by FGFR mutants | |
| Signaling by FGFR1 fusion mutants | |
| Signaling by SCF-KIT | |
| Smooth Muscle Contraction | |
| Synthesis of PIPs at the plasma membrane | |
| Tie2 Signaling | |
| VEGFA-VEGFR2 Pathway | |
| VEGFR2 mediated vascular permeability |